Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis

Immunology and Cell Biology

Volumn 89, Issue 7, 2011, Pages 817-822

  Takamura, Takeyuki ^a   Harama, Daisuke ^a   Fukumoto, Suguru ^a   Nakamura, Yuki ^a   Shimokawa, Naomi ^a   Ishimaru, Kayoko ^a   Ikegami, Shuji ^b   Makino, Seiya ^b   Kitamura, Masanori ^a   Nakao, Atsuhito ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

aryl hydrocarbon receptor; colitis; lactic acid bacterium; probiotics

Indexed keywords

ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; DEXTRAN SULFATE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; COLITIS; HUMAN; HUMAN CELL; LACTOBACILLUS; LACTOBACILLUS BULGARICUS OLL1181; LARGE INTESTINE; NONHUMAN;

ANIMALS; BENZOFLAVONES; CELL LINE, TUMOR; COLITIS, ULCERATIVE; COLON; CYTOCHROME P-450 CYP1A1; DEXTRAN SULFATE; FEMALE; HUMANS; LACTOBACILLUS; MICE; MICE, INBRED C57BL; PROBIOTICS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; MUS;

EID: 80053906324     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.165     Document Type: Article

References (25)

1. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995; 35: 307-340.
2. Barouki R, Coumoul X, Fernandez-Salguero PM. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 2007; 581: 3608-3615. (Pubitemid 47080995)
3. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009; 77: 713-722.
4. Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009; 30: 447-454.
5. Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 2009; 127: 299-311.
6. Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, Nohara K et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 2009; 206: 2027-2035.
7. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702. (Pubitemid 20069706)
8. Pizarro TT, Arseneau KO, Bamias G, Cominelli F. Mouse models for the study of Crohn's disease. Trends Mol Med 2003; 9: 218-222. (Pubitemid 36713392)
9. Takamura T, Harama D, Matsuoka S, Shimokawa N, Nakamura Y, Okumura K et al. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol 2010; 88: 685-689.
10. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001; 101: 229-238.
11. Sanders ME. Probiotics: considerations for human health. Nutrition Rev 2003; 61: 91-99. (Pubitemid 37259962)
12. Cross ML, Gill HS. Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int Arch Allergy Immunol 2001; 125: 112-119. (Pubitemid 32642048)
13. Herías MV, Koninkx JF, Vos JG, Huis in't Veld JH, van Dijk JE. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. Int J Food Microbiol 2005; 103: 143-155. (Pubitemid 41080476)
14. Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 2006; 6: 31.
15. Lee HS, Han SY, Bae EA, Huh CS, Ahn YT, Lee JH et al. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice. Int Immunopharmacol 2008; 8: 574-580.
16. Kasai A, Hiramatsu N, Meng Y, Yao J, Takeda M, Maeda S et al. DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal Biochem 2004; 335: 73-80. (Pubitemid 39446232)
17. Santovito D, Mezzetti A, Cipollone F. Cyclooxygenase and prostaglandin synthases: roles in plaque stability and instability in humans. Curr Opin Lipidol 2009; 20: 402-408.
18. Kasai A, Hiramatsu N, Meng Y, Yao J, Maeda S, Kitamura M. Fast-track DRESSA: a bioassay for fast, sensitive, and selective detection of halogenated and polycyclic aromatic hydrocarbons. Anal Biochem 2005; 337: 84-88. (Pubitemid 40092782)
19. Kasai A, Yao J, Yamauchi K, Hiramatsu N, Hayakawa K, Meng Y et al. Influence of cAMP on reporter bioassays for dioxin and dioxin-like compounds. Toxicol Appl Pharmacol 2006; 211: 11-19. (Pubitemid 43152093)
20. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003; 43: 309-334. (Pubitemid 37372644)
21. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001; 276: 31475-31478.
22. Seidel SD, Winters GM, Rogers WJ, Ziccardi MH, Li V, Keser B et al. Activation of the Ah receptor signaling pathway by prostaglandins. J Biochem Mol Toxicol 2001; 15: 187-196. (Pubitemid 32734325)
23. Neff-LaFord H, Teske S, Bushnell TP, Lawrence BP. Aryl hydrocarbon receptor activation during influenza virus infection unveils a novel pathway of IFN-g production by phagocytic cells. J Immunol 2007; 179: 247-255. (Pubitemid 46986540)
24. Nakamura Y, Miyata M, Ohba T, Ando T, Hatsushika K, Suenaga F et al. Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to T(H)2-type immune responses and airway inflammation. J Allergy Clin Immunol 2008; 122: 1208-1214.
25. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY et al. Loss of transforming growth factor-β signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001; 49: 190-198. (Pubitemid 32675110)